{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:28:38Z","timestamp":1793946518923,"version":"4.8.0"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.critrevonc.2026.105439","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T15:40:17Z","timestamp":1781970017000},"page":"105439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting ncRNA control networks with engineered exosomes to overcome therapy resistance in thyroid cancer"],"prefix":"10.1016","volume":"226","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0200-2886","authenticated-orcid":false,"given":"Anjani H.","family":"Turaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenden M.","family":"Finnerty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasa","family":"Zarnegar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Thomas J.","family":"Fahey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.critrevonc.2026.105439_bib1","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.3390\/cancers11091382","article-title":"Radioiodine-refractory thyroid cancer: molecular basis of redifferentiation therapies, management, and novel therapies","volume":"11","author":"Aashiq","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105439_bib2","article-title":"Modulatory role of miRNAs in thyroid and breast cancer progression and insights into their therapeutic manipulation","volume":"3","author":"Ahmed","year":"2022","journal-title":"Curr. Res. Pharmacol. Drug. Discov."},{"issue":"15","key":"10.1016\/j.critrevonc.2026.105439_bib3","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1089\/ars.2015.6616","article-title":"NADPH oxidase NOX4 is a critical mediator of BRAFV600E-induced downregulation of the sodium\/iodide symporter in papillary thyroid carcinomas","volume":"26","author":"Azouzi","year":"2017","journal-title":"Antioxid. Redox Signal."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105439_bib4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s13046-018-0936-7","article-title":"CircRNA circRNA_102171 promotes papillary thyroid cancer progression through modulating CTNNBIP1-dependent activation of \u03b2-catenin pathway","volume":"37","author":"Bi","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105439_bib5","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.beem.2016.10.001","article-title":"MicroRNAs in the thyroid","volume":"30","author":"Boufraqech","year":"2016","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105439_bib6","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1530\/ERC-14-0077","article-title":"miR-145 suppresses thyroid cancer growth and metastasis and targets AKT3","volume":"21","author":"Boufraqech","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"issue":"39","key":"10.1016\/j.critrevonc.2026.105439_bib7","doi-asserted-by":"crossref","first-page":"63106","DOI":"10.18632\/oncotarget.11056","article-title":"Phosphatidylinositide 3-kinase (PI3K) and PI3K-related kinase (PIKK) activity contributes to radioresistance in thyroid carcinomas","volume":"7","author":"Burrows","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2026.105439_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/618985","article-title":"Differentiated thyroid cancer: management of patients with radioiodine nonresponsive disease","volume":"2012","author":"Busaidy","year":"2012","journal-title":"J. Thyroid. Res."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105439_bib9","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1007\/s12094-021-02655-0","article-title":"Mechanisms of regulating NIS transport to the cell membrane and redifferentiation therapy in thyroid cancer","volume":"23","author":"Cai","year":"2021","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105439_bib10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.canlet.2020.08.021","article-title":"Non-coding RNA in thyroid cancer - functions and mechanisms","volume":"496","author":"Cao","year":"2021","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105439_bib11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12020-021-02847-2","article-title":"Analysis of serum microRNA in exosomal vehicles of papillary thyroid cancer","volume":"75","author":"Capriglione","year":"2022","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105439_bib12","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1158\/0008-5472.CAN-08-1982","article-title":"The beta-catenin axis integrates multiple signals downstream from RET\/papillary thyroid carcinoma leading to cell proliferation","volume":"69","author":"Castellone","year":"2009","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105439_bib13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.21873\/invivo.12262","article-title":"MicroRNA deregulation in papillary thyroid cancer and its relationship with BRAF V600E mutation","volume":"35","author":"Celakovsky","year":"2021","journal-title":"Vivo"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105439_bib14","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1172\/JCI46382","article-title":"Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation","volume":"121","author":"Chakravarty","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.critrevonc.2026.105439_bib15","doi-asserted-by":"crossref","DOI":"10.1177\/15330338211004950","article-title":"Knockdown of circ_NEK6 decreased 131I resistance of differentiated thyroid carcinoma via regulating miR-370-3p\/MYH9 axis","volume":"20","author":"Chen","year":"2021","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.critrevonc.2026.105439_bib16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.imlet.2022.04.004","article-title":"Circ_100395 impedes malignancy and glycolysis in papillary thyroid cancer: involvement of PI3K\/AKT\/mTOR signaling pathway","volume":"246","author":"Chen","year":"2022","journal-title":"Immunol. Lett."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105439_bib17","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1210\/jc.2015-3433","article-title":"Robust thyroid gene expression and radioiodine uptake induced by simultaneous suppression of BRAF V600E and histone deacetylase in thyroid cancer cells","volume":"101","author":"Cheng","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105439_bib18","first-page":"489","article-title":"miRNA146b is highly expressed in adult papillary","volume":"20","author":"Chou","year":"2010","journal-title":"Thyroid. Carcinomas High. risk Features Incl. Extra Invasion BRAF(V600E) Mutat. Thyroid."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105439_bib19","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3390\/ijms18030636","article-title":"MicroRNA-146b: a novel biomarker and therapeutic target for human papillary thyroid cancer","volume":"18","author":"Chou","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105439_bib20","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41568-024-00721-7","article-title":"Circular RNA in cancer","volume":"24","author":"Conn","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105439_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151968","article-title":"Family of microRNA-146 regulates RAR\u03b2 in papillary thyroid carcinoma","volume":"11","author":"Czajka","year":"2016","journal-title":"PLoS. One"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105439_bib22","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s10147-023-02400-3","article-title":"The diagnostic potential of two exosome-derived circRNAs for papillary thyroid cancer","volume":"28","author":"Dai","year":"2023","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105439_bib23","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41419-020-02827-w","article-title":"Exosomal lncRNA DOCK9-AS2 derived from cancer stem cell-like cells activated Wnt\/\u03b2-catenin pathway to aggravate stemness, proliferation, migration, and invasion in papillary thyroid carcinoma","volume":"11","author":"Dai","year":"2020","journal-title":"Cell. Death Dis."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105439_bib24","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.3390\/biomedicines10102585","article-title":"Role of extracellular vesicles in thyroid physiology and diseases: implications for diagnosis and treatment","volume":"10","author":"Delcorte","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105439_bib25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1677\/JOE-09-0436","article-title":"MTOR downregulates iodide uptake in thyrocytes","volume":"206","author":"de Souza","year":"2010","journal-title":"J. Endocrinol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105439_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4149\/neo_2021_210608N771","article-title":"circ_0067934 promotes the progression of papillary thyroid carcinoma cells through miR-1301-3p\/HMGB1 axis","volume":"69","author":"Dong","year":"2022","journal-title":"Neoplasma"},{"key":"10.1016\/j.critrevonc.2026.105439_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154281","article-title":"CircNRIP1: an emerging star in multiple cancers","volume":"241","author":"Du","year":"2023","journal-title":"Pathol. Res. Pract."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105439_bib28","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1210\/jc.2005-2838","article-title":"Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy","volume":"91","author":"Durante","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7146","key":"10.1016\/j.critrevonc.2026.105439_bib29","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nature05874","article-title":"Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project","volume":"447","author":"ENCODE Project","year":"2007","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105439_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3269","article-title":"Circ_0000144 facilitates the progression of thyroid cancer via the miR-217\/AKT3 pathway","volume":"22","author":"Fan","year":"2020","journal-title":"J. Gene Med."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105439_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228794","article-title":"TNF\u03b1-mediated activation of NF-\u03baB downregulates sodium-iodide symporter expression in thyroid cells","volume":"15","author":"Faria","year":"2020","journal-title":"PLoS. One"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105439_bib32","doi-asserted-by":"crossref","first-page":"E1139","DOI":"10.1210\/jc.2011-2748","article-title":"mTOR pathway overactivation in BRAF mutated papillary thyroid carcinoma","volume":"97","author":"Faustino","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2026.105439_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.596132","article-title":"The role of exosomes in thyroid cancer and their potential clinical application","volume":"10","author":"Feng","year":"2020","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105439_bib34","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.1210\/jc.2012-2564","article-title":"Inverse correlation of miRNA and cell cycle-associated genes suggests influence of miRNA on benign thyroid nodule tumorigenesis","volume":"98","author":"Ferraz","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105439_bib35","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1200\/JCO.21.01861","article-title":"Fusion oncogenes are associated with increased metastatic capacity and persistent disease in pediatric thyroid cancers","volume":"40","author":"Franco","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"31","key":"10.1016\/j.critrevonc.2026.105439_bib36","doi-asserted-by":"crossref","first-page":"10726","DOI":"10.1074\/jbc.RA119.012404","article-title":"Mediator complex subunit 16 is down-regulated in papillary thyroid cancer, leading to increased transforming growth factor-\u03b2 signaling and radioiodine resistance","volume":"295","author":"Gao","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"14","key":"10.1016\/j.critrevonc.2026.105439_bib37","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.3390\/cancers13143609","article-title":"TNF-\u03b1 may exert different antitumor effects in response to radioactive iodine therapy in papillary thyroid cancer with\/without autoimmune thyroiditis","volume":"13","author":"Gheorghe","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105439_bib38","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3892\/or.2020.7626","article-title":"Circular RNA expression and association with the clinicopathological characteristics in papillary thyroid carcinoma","volume":"44","author":"Guo","year":"2020","journal-title":"Oncol. Rep."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105439_bib39","first-page":"6815","article-title":"MicroRNA-9-5p functions as a tumor suppressor in papillary thyroid cancer via targeting BRAF","volume":"16","author":"Guo","year":"2018","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105439_bib40","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ccr.2010.08.013","article-title":"Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21","volume":"18","author":"Hatley","year":"2010","journal-title":"Cancer Cell."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105439_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105439_bib42","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.3390\/cancers12113118","article-title":"MicroRNA in papillary thyroid carcinoma: a systematic review from 2018 to June 2020","volume":"12","author":"Hitu","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105439_bib43","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1089\/thy.2015.0578","article-title":"MiR-20b displays tumor-suppressor functions in papillary thyroid carcinoma by regulating the MAPK\/ERK signaling pathway","volume":"26","author":"Hong","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.critrevonc.2026.105439_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.566365","article-title":"Downregulation of miR-146b-3p inhibits proliferation and migration and modulates the expression and location of sodium\/iodide symporter in dedifferentiated thyroid cancer by potentially targeting MUC20","volume":"10","author":"Hou","year":"2021","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105439_bib45","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3892\/etm.2022.11566","article-title":"Circular RNA PVT1 promotes progression of thyroid cancer by competitively binding miR-384","volume":"24","author":"Hua","year":"2022","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105439_bib46","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13046-023-02670-9","article-title":"The \u03b2-catenin-LINC00183-miR-371b-5p-Smad2\/LEF1 axis promotes adult T-cell lymphoblastic lymphoma progression and chemoresistance","volume":"42","author":"Huang","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105439_bib47","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1111\/cas.15772","article-title":"ALKBH5-induced circular RNA NRIP1 promotes glycolysis in thyroid cancer cells by targeting PKM2","volume":"114","author":"Ji","year":"2023","journal-title":"Cancer Sci."},{"issue":"18","key":"10.1016\/j.critrevonc.2026.105439_bib48","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.7150\/jca.60885","article-title":"PSD3 is an oncogene that promotes proliferation, migration, invasion, and G1\/S transition while inhibits apoptotic in papillary thyroid cancer","volume":"12","author":"Jin","year":"2021","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105439_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-42941-1","article-title":"Identification of transcriptional level variations in microRNA-221 and microRNA-222 as alternate players in the thyroid cancer tumor microenvironment","volume":"13","author":"Khan","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105439_bib50","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/ERC-14-0439","article-title":"microRNA-339-5p modulates Na+\/I- symporter-mediated radioiodide uptake","volume":"22","author":"Lakshmanan","year":"2015","journal-title":"Endocr. Relat. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105439_bib51","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3892\/or.2016.5228","article-title":"Inhibiting \u03b2-catenin expression promotes efficiency of radioiodine treatment in aggressive follicular thyroid cancer cells probably through mediating NIS localization","volume":"37","author":"Lan","year":"2017","journal-title":"Oncol. Rep."},{"issue":"24","key":"10.1016\/j.critrevonc.2026.105439_bib52","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1002\/cncr.28254","article-title":"MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer","volume":"119","author":"Lee","year":"2013","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105439_bib53","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13000-021-01153-9","article-title":"CircRNA NRIP1 promotes papillary thyroid carcinoma progression by sponging miRNA195-5p and modulating the P38 MAPK and JAK\/STAT pathways","volume":"16","author":"Li","year":"2021","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105439_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118622","article-title":"Circ_PSD3 promotes the progression of papillary thyroid carcinoma via the miRNA637\/HEMGN axis","volume":"264","author":"Li","year":"2021","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105439_bib55","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2967\/jnumed.119.227652","article-title":"The genetic duet of BRAF V600E and TERT promoter mutations robustly predicts loss of radioiodine avidity in recurrent papillary thyroid cancer","volume":"61","author":"Liu","year":"2020","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.critrevonc.2026.105439_bib56","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41420-022-01214-y","article-title":"Pyruvate carboxylase promotes malignant transformation of papillary thyroid carcinoma and reduces iodine uptake","volume":"8","author":"Liu","year":"2022","journal-title":"Cell. Death Discov."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105439_bib57","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.sjbs.2018.05.014","article-title":"MicroRNA-4728 mediated regulation of MAPK oncogenic signaling in papillary thyroid carcinoma","volume":"25","author":"Liu","year":"2018","journal-title":"Saudi J. Biol. Sci."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105439_bib58","doi-asserted-by":"crossref","first-page":"7749","DOI":"10.1007\/s13277-015-4611-8","article-title":"microRNA-137 is downregulated in thyroid cancer and inhibits proliferation and invasion by targeting EGFR","volume":"37","author":"Luo","year":"2016","journal-title":"Tumour Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105439_bib59","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40463-022-00574-w","article-title":"Circ_0000144 acts as a miR-1178-3p decoy to promote cell malignancy and angiogenesis by increasing YWHAH expression in papillary thyroid cancer","volume":"51","author":"Ma","year":"2022","journal-title":"J. Otolaryngol. Head. Neck Surg."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105439_bib60","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s12020-022-03267-6","article-title":"Expression of miRNA31-5p affects growth, migration and invasiveness of papillary thyroid cancer cells","volume":"79","author":"Maggisano","year":"2023","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105439_bib61","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1530\/ERC-15-0445","article-title":"Recent incidences and differential trends of thyroid cancer in the USA","volume":"23","author":"Mao","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105439_bib62","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1172\/JCI89067","article-title":"Sustained ERK inhibition maximizes responses of BrafV600E thyroid cancers to radioiodine","volume":"126","author":"Nagarajah","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.critrevonc.2026.105439_bib63","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105439_bib64","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1677\/erc.1.01209","article-title":"MicroRNA deregulation in human thyroid papillary carcinomas","volume":"13","author":"Pallante","year":"2006","journal-title":"Endocr. Relat. Cancer"},{"issue":"15","key":"10.1016\/j.critrevonc.2026.105439_bib65","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1158\/1078-0432.CCR-21-0874","article-title":"Oncogenic mutations in PI3K\/AKT\/mTOR pathway effectors associate with worse prognosis in BRAFV600E-driven papillary thyroid cancer patients","volume":"27","author":"Pappa","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105439_bib66","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3389\/fonc.2020.00941","article-title":"The role of long non-coding RNAs in thyroid cancer","volume":"10","author":"Peng","year":"2020","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105439_bib67","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3390\/ijms17060909","article-title":"The role of miRNA in papillary thyroid cancer in the context of miRNA Let-7 family","volume":"17","author":"Perdas","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105439_bib68","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ctrv.2015.06.005","article-title":"PI3K\/Akt\/mTOR: a promising therapeutic target for non-medullary thyroid carcinoma","volume":"41","author":"Petrulea","year":"2015","journal-title":"Cancer Treat. Rev."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105439_bib69","doi-asserted-by":"crossref","first-page":"E1368","DOI":"10.1210\/jc.2014-1171","article-title":"mTOR inhibition promotes TTF1-dependent redifferentiation and restores iodine uptake in thyroid carcinoma cell lines","volume":"99","author":"Plantinga","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2026.105439_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1365032","article-title":"Circular RNA PRKCI (hsa_circ_0067934): a potential target in the pathogenesis of human malignancies","volume":"14","author":"Qiu","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105439_bib71","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.gene.2017.08.024","article-title":"RasGRP3 controls cell proliferation and migration in papillary thyroid cancer by regulating the Akt-MDM2 pathway","volume":"633","author":"Qiu","year":"2017","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105439_bib72","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrg.2015.10","article-title":"Unique features of long non-coding RNA biogenesis and function","volume":"17","author":"Quinn","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.critrevonc.2026.105439_bib73","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3389\/fendo.2019.00430","article-title":"miRNA-directed regulation of the main signaling pathways in thyroid cancer","volume":"10","author":"Ram\u00edrez-Moya","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.critrevonc.2026.105439_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.795386","article-title":"AhR antagonist promotes differentiation of papillary thyroid cancer via regulating circSH2B3\/miR-4640\u20135\u2009P\/IGF2BP2 axis","volume":"12","author":"Sa","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105439_bib75","doi-asserted-by":"crossref","first-page":"12011","DOI":"10.1007\/s13277-016-5065-3","article-title":"Plasma exosomal miR-21 and miR-181a differentiates follicular from papillary thyroid cancer","volume":"37","author":"Samsonov","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.critrevonc.2026.105439_bib76","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fendo.2012.00031","article-title":"Role of the wnt pathway in thyroid cancer","volume":"3","author":"Sastre-Perona","year":"2012","journal-title":"Front. Endocrinol. (Lausanne"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105439_bib77","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/17446651.2024.2347275","article-title":"Hormonal influences on cerebral aneurysms: unraveling the complex connections","volume":"19","author":"Segherlou","year":"2024","journal-title":"Expert. Rev. Endocrinol. Metab."},{"issue":"16","key":"10.1016\/j.critrevonc.2026.105439_bib78","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.3390\/cancers16162892","article-title":"Image-Guided Mesenchymal Stem Cell Sodium Iodide Symporter (NIS) Radionuclide Therapy for Glioblastoma","volume":"16","author":"Shah","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105439_bib79","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13046-016-0377-0","article-title":"miRNA-106a directly targeting RARB associates with the expression of Na(+)\/I(-) symporter in thyroid cancer by regulating MAPK signaling pathway","volume":"35","author":"Shen","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105439_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.101013","article-title":"Radioiodine-refractory differentiated thyroid cancer: molecular mechanisms and therapeutic strategies for radioiodine resistance","volume":"72","author":"Shen","year":"2024","journal-title":"Drug. Resist. Updat."},{"key":"10.1016\/j.critrevonc.2026.105439_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1252389","article-title":"Global research landscape and trends of papillary thyroid cancer therapy: a bibliometric analysis","volume":"14","author":"Song","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105439_bib82","first-page":"1847","article-title":"A somatic mutation of RasGRP3 decreases Na+\/I- symporter expression in metastases of radioactive iodine-refractory thyroid cancer by stimulating the Akt signaling pathway","volume":"8","author":"Song","year":"2018","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105439_bib83","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.mce.2017.07.020","article-title":"Long non-coding RNAs in thyroid cancer: biological functions and clinical significance","volume":"469","author":"Sui","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.critrevonc.2026.105439_bib84","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1337226","article-title":"Exosomal noncoding RNAs: decoding their role in thyroid cancer progression","volume":"15","author":"Sun","year":"2024","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105439_bib85","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.3390\/cancers12113264","article-title":"Non-coding RNAs: uncharted mediators of thyroid cancer pathogenesis","volume":"12","author":"Tabatabaeian","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105439_bib86","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-75087-9","article-title":"TERT promoter mutations contribute to adverse clinical outcomes and poor prognosis in radioiodine refractory differentiated thyroid cancer","volume":"14","author":"Tan","year":"2024","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105439_bib87","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.3390\/ijms19051448","article-title":"mTOR pathway in papillary thyroid carcinoma: different contributions of mTORC1 and mTORC2 complexes for tumor behavior and SLC5A5 mRNA expression","volume":"19","author":"Tavares","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105439_bib88","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41416-021-01584-7","article-title":"Unravelling similarities and differences in the role of circular and linear PVT1 in cancer and human disease","volume":"126","author":"Traversa","year":"2022","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105439_bib89","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.cell.2018.12.021","article-title":"The landscape of circular RNA in cancer","volume":"176","author":"Vo","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105439_bib90","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.12659\/MSM.913463","article-title":"CircRNA circ_0067934 overexpression correlates with poor prognosis and promotes thyroid carcinoma progression","volume":"25","author":"Wang","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.critrevonc.2026.105439_bib91","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4378345","article-title":"Exosomes as mediators of cell-to-cell communication in thyroid disease","volume":"2020","author":"Wang","year":"2020","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.critrevonc.2026.105439_bib92","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.gene.2019.01.016","article-title":"A three plasma microRNA signature for papillary thyroid carcinoma diagnosis in Chinese patients","volume":"693","author":"Wang","year":"2019","journal-title":"Gene"},{"key":"10.1016\/j.critrevonc.2026.105439_bib93","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.2147\/OTT.S190364","article-title":"MicroRNA-221 promotes papillary thyroid carcinoma cell migration and invasion via targeting RECK and regulating epithelial-mesenchymal transition","volume":"12","author":"Wei","year":"2019","journal-title":"Onco Targets Ther."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105439_bib94","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2967\/jnumed.116.180240","article-title":"TERT promoter mutation predicts radioiodine-refractory character in distant metastatic differentiated thyroid cancer","volume":"58","author":"Yang","year":"2017","journal-title":"J. Nucl. Med."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105439_bib95","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3892\/etm.2021.10084","article-title":"miR-221-3p and miR-222-3p regulate the SOCS3\/STAT3 signaling pathway to downregulate the expression of NIS and reduce radiosensitivity in thyroid cancer","volume":"21","author":"Ye","year":"2021","journal-title":"Exp. Ther. Med."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105439_bib96","doi-asserted-by":"crossref","first-page":"516","DOI":"10.4149\/neo_2018_180824N643","article-title":"Exosomal miRNA423-5p mediated oncogene activity in papillary thyroid carcinoma: a potential diagnostic and biological target for cancer therapy","volume":"66","author":"Ye","year":"2019","journal-title":"Neoplasma"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105439_bib97","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/ijc.22701","article-title":"Identification of a novel noncoding RNA gene, NAMA, that is downregulated in papillary thyroid carcinoma with BRAF mutation and associated with growth arrest","volume":"121","author":"Yoon","year":"2007","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105439_bib98","doi-asserted-by":"crossref","first-page":"33","DOI":"10.21873\/anticanres.13077","article-title":"MicroRNA expression in the progression and aggressiveness of papillary thyroid carcinoma","volume":"39","author":"Zembska","year":"2019","journal-title":"Anticancer. Res."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105439_bib99","doi-asserted-by":"crossref","first-page":"11795","DOI":"10.1080\/21655979.2021.2008639","article-title":"Circular RNA Pvt1 oncogene (CircPVT1) promotes the progression of papillary thyroid carcinoma by activating the Wnt\/\u03b2-catenin signaling pathway and modulating the ratio of microRNA-195 (miR-195) to vascular endothelial growth factor A (VEGFA) expression","volume":"12","author":"Zeng","year":"2021","journal-title":"Bioengineered"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105439_bib100","doi-asserted-by":"crossref","first-page":"150","DOI":"10.14715\/cmb\/2024.70.2.21","article-title":"Circ-LDLRAD3\/miR-655-3p\/MAPK1 axis enhances cell migration and invasion in papillary thyroid carcinoma","volume":"70","author":"Zhang","year":"2024","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105439_bib101","first-page":"1199","article-title":"MiR-222-3p promotes the proliferation, migration and invasion of papillary thyroid carcinoma cells through targeting SLC4A4","volume":"36","author":"Zhang","year":"2021","journal-title":"Histol. Histopathol."},{"issue":"13","key":"10.1016\/j.critrevonc.2026.105439_bib102","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.7150\/ijms.44723","article-title":"MiR-145 functions as a tumor suppressor in papillary thyroid cancer by inhibiting RAB5C","volume":"17","author":"Zhang","year":"2020","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.critrevonc.2026.105439_bib103","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jare.2025.09.028","article-title":"Cancer stem cell plasticity in shaping drug resistance landscapes in prostate cancer","volume":"84","author":"Zhang","year":"2026","journal-title":"J. Adv. Res."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105439_bib104","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1530\/ERC-13-0399","article-title":"Histone deacetylation of NIS promoter underlies BRAF V600E-promoted NIS silencing in thyroid cancer","volume":"21","author":"Zhang","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105439_bib105","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41417-024-00736-0","article-title":"Emerging roles of circular RNAs in regulating the hallmarks of thyroid cancer","volume":"31","author":"Zhou","year":"2024","journal-title":"Cancer Gene Ther."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105439_bib106","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/10799893.2021.1910706","article-title":"circ-PSD3 promoted proliferation and invasion of papillary thyroid cancer cells via regulating the miR-7-5p\/METTL7B axis","volume":"42","author":"Zhu","year":"2022","journal-title":"J. Recept. Signal. Transduct. Res."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826003264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826003264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:39:37Z","timestamp":1793943577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826003264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":106,"alternative-id":["S1040842826003264"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105439","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting ncRNA control networks with engineered exosomes to overcome therapy resistance in thyroid cancer","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105439","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105439"}}